作者：
Pugsley, M. K. [1]
;
Authier, S. [2]
;
Koerner, J. E. [3]
;
Redfern, W. S. [4]
;
Markgraf, C. G. [5]
;
Brabham, T. [6]
;
Correll, K. [7]
;
Soloviev, M. V. [8]
;
Botchway, A. [9]
;
Engwall, M. [10]
;
Traebert, M. [11]
;
Valentin, J. -P. [12]
;
Mow, T. J. [13]
;
Greiter-Wilke, A. [14]
;
Leishman, D. J. [15]
;
Vargas, H. M.
作者单位：
UCB Biopharma, Brussels, Belgium
[1]
CiToxLAB North Amer, Laval, PQ, Canada
[2]
US FDA, Silver Spring, MD USA
[3]
AstraZeneca, IMED Biotech Unit, Safety & ADME Translat Sci, Cambridge, England
[4]
Teva Pharmaceut, N Wales, PA 19454 USA
[5]
Safety Pharmacol Soc, Reston, VA 20191 USA
[6]
Novartis Pharma AG, Basel, Switzerland
[7]
Novo Nordisk, Copenhagen, Denmark
[8]
Amgen Inc, Thousand Oaks, CA 91320 USA
[9]
Eli Lilly, Indianapolis, IN USA
[10]
Sunov Pharmaceut Inc, Marlborough, MA 01752 USA
[11]
Xenometr LLC, Stilwell, KS 66085 USA
[12]
F Hoffmann La Roche Ltd, Basel, Switzerland
[13]
Incyte Corp, Wilmington, DE 19803 USA
[14]
Purdue Pharma LP, Stamford, CT 06901 USA
[15]
发布时间
2019-09-17
换一批
